Text Size

Quality indicators to ensure excellence in glaucoma care: the GlauCCare Spanish consensus

Munoz-Negrete F.J.; Garcia-Feijoo J.; Millá E.; Pablo-Júlvez L.; Urcola J.A.; Camunas-Sevilla C.; Rubial-Bernárdez F.; Rodríguez-Vázquez M.C.


  • 2025
  • BMJ Open Ophthalmology
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Other

  • Affiliations

    Ophthalmology, Hospital Universitario Ramón y Cajal, Madrid, Spain; Ophthalmology, Hospital Clínico Universitario San Carlos, Madrid, Spain; Ophthalmology, Hospital Clinic de Barcelona, Barcelona, Spain; Ophthalmology, Hospital Universitario Miguel Servet, Zaragoza, Spain; Ophthalmology, Hospital Universitario de Álava, Vitoria, Spain; Quality, Hospital Universitario de Toledo, Toledo, Spain; Área Sanitaria de Lugo, A Mariña e Monforte de Lemos, Lugo, Spain; Market Access, Santen Pharmaceutical Spain S.L, Madrid, Spain

Related Publications

Long-term safety and efficacy of sepetaprost, with or without timolol, in patients with open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J2 study

Inatani M., Tone Y., Ikeda T., Angeles R.


Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study

Inatani M., Kanamori A., Inai M., Ikeda T., Angeles R.


Clinical outcomes of Preserflo MicroShunt implant procedure in open‑angle glaucoma patients – a 1000 eyes case-series; including subanalysis of combined cataract-glaucoma surgery and standalone surgery in pseudophakic eyes

Klabe, K.; Werth, J.P.; Kaymak, H. ; Fricke, A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022